Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Cost of Revenue (2016 - 2025)

Apyx Medical (APYX) has disclosed Cost of Revenue for 15 consecutive years, with $7.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 36.27% year-over-year to $7.2 million, compared with a TTM value of $19.8 million through Dec 2025, up 5.65%, and an annual FY2025 reading of $19.8 million, up 5.65% over the prior year.
  • Cost of Revenue was $7.2 million for Q4 2025 at Apyx Medical, up from $4.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $7.2 million in Q4 2025 and bottomed at $2.8 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $4.4 million, with a median of $4.3 million recorded in 2023.
  • The sharpest move saw Cost of Revenue soared 69.36% in 2021, then decreased 12.34% in 2025.
  • Year by year, Cost of Revenue stood at $4.7 million in 2021, then fell by 6.48% to $4.4 million in 2022, then skyrocketed by 31.19% to $5.7 million in 2023, then fell by 8.29% to $5.3 million in 2024, then soared by 36.27% to $7.2 million in 2025.
  • Business Quant data shows Cost of Revenue for APYX at $7.2 million in Q4 2025, $4.6 million in Q3 2025, and $4.3 million in Q2 2025.